More than 50% of human cancers bear mutations in TP53, the gene coding for the transcription factor p53.3 These TP53 mutations may dysregulate the native tumor suppressing characteristics of p53, whereas contributing to gain of oncogenic features. This evidence concerns the gene TP53 and cancer.